These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35313783)

  • 1. Deferoxamine ameliorated Al(mal)
    Zhu D; Liang R; Liu Y; Li Z; Cheng L; Ren J; Guo Y; Wang M; Chai H; Niu Q; Yang S; Bai J; Yu H; Zhang H; Qin X
    Toxicol Mech Methods; 2022 Sep; 32(7):530-541. PubMed ID: 35313783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of DFO in Al (mal) (3)-induced ferroptosis in PC12 cells].
    Cheng LT; Li Z; Ren JJ; Niu Q; Yu HM; Liang RF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2019 Oct; 37(10):722-727. PubMed ID: 31726500
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminum maltolate triggers ferroptosis in neurons: mechanism of action.
    Cheng L; Liang R; Li Z; Ren J; Yang S; Bai J; Niu Q; Yu H; Zhang H; Xia N; Liu H
    Toxicol Mech Methods; 2021 Jan; 31(1):33-42. PubMed ID: 32900247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina.
    Sakamoto K; Suzuki T; Takahashi K; Koguchi T; Hirayama T; Mori A; Nakahara T; Nagasawa H; Ishii K
    Exp Eye Res; 2018 Jun; 171():30-36. PubMed ID: 29530811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron deposition participates in LPS-induced cognitive impairment by promoting neuroinflammation and ferroptosis in mice.
    Li Y; Ruan X; Sun M; Yuan M; Song J; Zhou Z; Li H; Ma Y; Mi W; Zhang X
    Exp Neurol; 2024 Sep; 379():114862. PubMed ID: 38866103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
    Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hippocampal neuronal ferroptosis involved in cognitive dysfunction in rats with sepsis-related encephalopathy through the Nrf2/GPX4 signaling pathway].
    Yao P; Chen Y; Li Y; Zhang Y; Qi H; Xu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1389-1394. PubMed ID: 31898571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury.
    Jia H; Liu X; Cao Y; Niu H; Lan Zhang ; Li R; Li F; Sun D; Shi M; Wa L; Liu X; Yang G; Chen F; Zhang S; Zhang J
    Brain Res; 2023 Aug; 1812():148383. PubMed ID: 37149247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relieving ferroptosis may partially reverse neurodegeneration of the auditory cortex.
    Chen X; Li D; Sun HY; Wang WW; Wu H; Kong W; Kong WJ
    FEBS J; 2020 Nov; 287(21):4747-4766. PubMed ID: 32112499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiently suppress of ferroptosis using deferoxamine nanoparticles as a new method for retinal ganglion cell protection after traumatic optic neuropathy.
    Lin S; Gao W; Zhu C; Lou Q; Ye C; Ren Y; Mehmood R; Huang B; Nan K
    Biomater Adv; 2022 Jul; 138():212936. PubMed ID: 35913229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia.
    Wu T; Liang X; Liu X; Li Y; Wang Y; Kong L; Tang M
    Part Fibre Toxicol; 2020 Jul; 17(1):30. PubMed ID: 32652997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease.
    Bao WD; Pang P; Zhou XT; Hu F; Xiong W; Chen K; Wang J; Wang F; Xie D; Hu YZ; Han ZT; Zhang HH; Wang WX; Nelson PT; Chen JG; Lu Y; Man HY; Liu D; Zhu LQ
    Cell Death Differ; 2021 May; 28(5):1548-1562. PubMed ID: 33398092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferoxamine reduces endothelial ferroptosis and protects cerebrovascular function after experimental traumatic brain injury.
    Liang Y; Wang Y; Sun C; Xiang Y; Deng Y
    Brain Res Bull; 2024 Feb; 207():110878. PubMed ID: 38218407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine-induced neurite outgrowth and synapse formation in postnatal rat dorsal root ganglion (DRG) cell cultures.
    Nowicki M; Kosacka J; Spanel-Borowski K; Borlak J
    Eur J Cell Biol; 2009 Oct; 88(10):551-62. PubMed ID: 19581022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of deferoxamine on enzymatic stress markers in an animal model of Alzheimer's disease after chronic aluminum exposure.
    Esparza JL; Garcia T; Gómez M; Nogués MR; Giralt M; Domingo JL
    Biol Trace Elem Res; 2011 Jun; 141(1-3):232-45. PubMed ID: 20455029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis contributes to hemolytic hyperbilirubinemia‑induced brain damage in vivo and in vitro.
    Zhou J; Lin X; Liao S; Li G; Tang J; Luo J; Zhang C; Wu S; Xu L; Li H
    Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37937619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction.
    Zeinivand M; Nahavandi A; Zare M
    Inflammopharmacology; 2020 Apr; 28(2):575-583. PubMed ID: 31786804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.
    Ma S; Henson ES; Chen Y; Gibson SB
    Cell Death Dis; 2016 Jul; 7(7):e2307. PubMed ID: 27441659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of deferoxamine on lead-induced cardiotoxicity in rats.
    Gazeri A; Aminzadeh A
    Toxicol Ind Health; 2020 Oct; 36(10):800-806. PubMed ID: 32812511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.